Page last updated: 2024-11-05

ici 204,219 and Carcinoma, Hepatocellular

ici 204,219 has been researched along with Carcinoma, Hepatocellular in 2 studies

zafirlukast: a leukotriene D4 receptor antagonist

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, S1
Zhang, L1
Chen, Y1
Fu, L1
Kumar, P1
Agarwal, A1
Singh, AK1
Gautam, AK1
Chakraborti, S1
Kumar, U1
Kumar, D1
Bhattacharya, B1
Panda, P1
Saha, B1
Qidwai, T1
Maity, B1
Saha, S1

Reviews

1 review available for ici 204,219 and Carcinoma, Hepatocellular

ArticleYear
Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential.
    Journal of medicinal chemistry, 2022, 10-13, Volume: 65, Issue:19

    Topics: Carcinoma, Hepatocellular; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Interf

2022

Other Studies

1 other study available for ici 204,219 and Carcinoma, Hepatocellular

ArticleYear
Antineoplastic properties of zafirlukast against hepatocellular carcinoma via activation of mitochondrial mediated apoptosis.
    Regulatory toxicology and pharmacology : RTP, 2019, Volume: 109

    Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Hepatocellular;

2019